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Neural retinaDespite very different aetiologies, age-relatedmacular degeneration (AMD) andmost inherited retinal disorders
culminate in the same ﬁnal common pathway, loss of the light-sensitive photoreceptors. There are few clinical
treatments and none can reverse the loss of vision. Photoreceptor replacement by transplantation is proposed
as a broad treatment strategy applicable to all degenerations. The past decade has seen a number of landmark
achievements in this ﬁeld, which together provide strong justiﬁcation for continuing investigation into photore-
ceptor replacement strategies. These include proof of principle for restoring vision by rod-photoreceptor trans-
plantation in mice with congenital stationary night blindness and advances in stem cell biology, which have
led to the generation of complete optic structures in vitro from embryonic stem cells. The latter represents enor-
mous potential for generating suitable and renewable donor cells with which to achieve the former. However,
there are still challenges presented by the degenerating recipient retinal environment that must be addressed
as we move to translating these technologies towards clinical application.
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Retinal degenerations leading to the loss of the light sensitive photo-
receptors are amajor cause of untreatable blindness in the UK. Inherited
retinal dystrophies affect 1 in 3000 of the population, and Age-Relateded.
486 R.A. Pearson / Biotechnology Advances 32 (2014) 485–491Macular Degeneration (AMD) affects 1 in 10 people over 60 years, a ﬁg-
ure that is rising with an ageing population (Owen et al., 2012). Both
conditions culminate in the same ﬁnal common pathway, the loss of
the light-sensing photoreceptors, which causes severe or complete
loss of vision. In each case, there are few effective treatments and
none of those currently available is able to replace lost photoreceptor
cells and restore visual function. There is thus a need for new therapeu-
tic approaches. Photoreceptors are afferent neurons and as such require
no incoming connections. Moreover, they need only to make short, sin-
gle synaptic connections to the remaining inner retinal circuitry to con-
tribute to visual function. These features, arguably, make photoreceptor
transplantation one of the most feasible types of Central Nervous Sys-
tem (CNS) repair and an excellent candidate for exploring regenerative
neural stem cell therapies. The past decade has seen enormous progress
in novel ocular therapies, including the ﬁrst gene therapy (Bainbridge
et al., 2008; Maguire et al., 2008) and retinal implant based (Chader
et al., 2009) clinical trials for retinal disease, which have set the scene
for pioneering new therapies for retinal disease. The success of gene
therapy relies on the delivery of new functional genes to cells that lack
such genes and is therefore dependent upon endogenous cell survival.
In cases where the degenerative process has already led to cell death
or in those conditions that are not amenable to gene therapy ap-
proaches, cell replacement therapies may offer a complementary ap-
proach. Given its accessibility, the eye has also been the model of
choice for the study of neural development. As such, there is a wealth
of knowledge regarding the intrinsic and extrinsic factors that regulate
retinal histogenesis, knowledge that is now being employed to great ef-
fect in attempts to generate retinal cells from stem cells for transplanta-
tion (Eiraku et al., 2011; Lamba et al., 2009; Osakada et al., 2009). In this
review, I will present a brief overview of the progress in photoreceptor
replacement, in our ability to generate photoreceptors from stem cells
and discuss some of the challenges that must be addressed as we
begin to take this strategy towards clinical application.
2. Critique and discussion
2.1. Transplantation strategies
2.1.1. Retinal sheet transplantation
A central requirement of successful photoreceptor replacement
therapy is the identiﬁcation of an appropriate donor cell that has the
ability to both migrate into the recipient retina following transplanta-
tion and differentiate into a fully functional, synaptically connected
photoreceptor. Several transplantation strategies have been attempted,
including the transplantation of whole sheets and microaggregates of
developing neural retina and of dissociated adult hippocampal neural
stem cells.
Work by Aramant and others have demonstrated that whole retinal
sheets derived from either embryonic or neonatal retinae can survive
and continue to differentiate after subretinal transplantation (Ghosh
et al., 2004; Turner et al., 1988). More recently, they have shown that
full-thickness retinal sheets canmake limited connectionswith the recip-
ient retina (Seiler et al., 2008). While there were some improvements in
basic visual responses, for example light–dark discrimination, some au-
thors have attributed this to the enhanced survival and function of endog-
enous photoreceptors by means of trophic factors released from the
healthy transplanted tissue (Gouras and Tanabe, 2003). To date, retinal
sheet transplantation in patients has shown some subjective visual im-
provement (Humayun et al., 2000; Radtke et al., 1999). A clinical study
of retinitis pigmentosa (RP) andAMDpatientswho received foetal retinal
sheet transplants (neural retina and retinal pigment epithelium, [RPE]),
reported improvements in vision for 7 out of 10 patients, although the di-
rect beneﬁcial effects of the foetal retinal grafts are difﬁcult to assess as all
patients also received intraocular lens implants (Radtke et al., 2008). A
further complication of full thickness retinal sheets is the inclusion of
the inner retinal neurons that by deﬁnition are juxtaposed between thegraft photoreceptors and the inner retinal neurons of the recipient retina.
It remains to be determined to what degree this affects the processing of
visual signals within the retina and beyond. An interesting related
approach is the use of partial thickness grafts, encompassing the photore-
ceptor layer but omitting the inner retinal layer of the donor retina
(Ghosh et al., 1999). Such a strategy might be of interest in severely
degenerate retinas where the endogenous photoreceptor layer is com-
pletely absent although results to date have indicated only limited con-
nectivity between the graft and the recipient retina.
2.1.2. Transplantation of dissociated cells
The limited integration between sheets and the recipient visual cir-
cuitry has prompted many groups to look at the transplantation of dis-
sociated cell types. Given that the brain and the retina are both derived
from the neuroectoderm and that immature neurons and progenitor
cells are intrinsically capable of migrating and differentiating during
neural development, numerous studies have investigated the potential
of brain-derived neural stem/progenitor cells transplanted to the neural
retina (Klassen et al., 2007; Mellough et al., 2007; Sakaguchi et al.,
2004). However, transplantation of these cells into the adult retina has
demonstrated only limited integration (Sakaguchi et al., 2005; Young
et al., 2000). Moreover, these non-retinal sources of donor cells fre-
quently fail to differentiate into mature retinal phenotypes, including
photoreceptors, as assessed by immunohistochemistry (Young et al.,
2000). More recent studies using tissue-restricted reporter genes to
demonstrate retinal cell fate have conﬁrmed that the integrated cells
derived from such sources do not exhibit intrinsic features of mature
retinal neurons (Sam et al., 2006).
To address this problem, progenitor cells isolated from embryonic
retinas, which by deﬁnition possess the potential to differentiate into
retinal neurons, have been tried; depending upon the conditions used
to expand these cells in vitro prior to transplantation, these cells survive
and differentiate into glial cells (Yang et al., 2002) and/or cells express-
ing retinal-speciﬁc markers, including some speciﬁc for photoreceptors
(Qiu et al., 2005) upon transplantation. However, they also fail to be-
come correctly integratedwithin the laminar structure of the neural ret-
ina, remaining instead at the site of transplantation. Greater success has
been achieved when transplanting immature retinal cells into imma-
ture recipients, suggesting that the maturation state of the recipient
may play a role in determining transplantation outcome: Murine pro-
genitor cells transplanted into the eyes of neonatal Brazilian Opossums,
which provide a foetal-like environment, survived and differentiated
in vivo, although integrated cellswere not foundwithin the outer nucle-
ar layer (ONL), where photoreceptors normally reside (Sakaguchi et al.,
2004). Since the same donor cells failed to migrate into the retina of
more mature recipients, it was suggested that the age of the host tissue
had a key role in determining the fate of transplanted precursor cells
and their ability to integrate into the circuitry of a non-autologous retina
(Sakaguchi et al., 2003, 2004; Van Hoffelen et al., 2003).
By using postnatal donor cells from a transgenic mouse ubiquitously
expressing Green Fluorescent Protein (GFP) and taking these cells from
the peak of rod photoreceptor genesis and transplanting them into re-
cipients of exactly the same developmental stage, MacLaren & Pearson
et al., found that the transplanted cells migrated into the ONL (and no
other layer) of the recipient retina and matured into morphologically
normal photoreceptors. Moreover, these same cells could also integrate
with equivalent efﬁciency into the non-neurogenic, adult retinal envi-
ronment (MacLaren et al., 2006), as well as a number of models of reti-
nal degeneration (Barber et al., 2013, 2008; MacLaren et al., 2006;
Pearson et al., 2010) (but see further discussion). This indicated that
transplantation success depended upon the developmental stage of
the donor cell, rather than that of the recipient (Fig. 1).
Importantly, by using another transgenic model, in which GFP ex-
pression is under the control of the rod-speciﬁc transcription factor
Nrl, which is ﬁrst expressed shortly after terminal mitosis (Akimoto
et al., 2006), the authors were able to demonstrate that these results
487R.A. Pearson / Biotechnology Advances 32 (2014) 485–491are only achieved using post-mitotic photoreceptor precursor cells, cells
that are speciﬁed to differentiate into rod photoreceptors, but not
progenitor cells or photoreceptors at other stages of development
(Lakowski et al., 2010; MacLaren et al., 2006; Pearson et al., 2012). In
contrast, work by Reh and colleagues reported that fully mature photo-
receptors taken from the adult retina could also integrate within the
wild type retina with similar efﬁciency but exhibited poorer survival
(Gust and Reh, 2011). However, more recent reports have consistently
demonstrated that while it is possible for mature photoreceptors to in-
tegrate, they do so withmarkedly lower efﬁciency, even when account-
ing for reduced viability (Gonzalez-Cordero et al., 2013; Pearson et al.,
2012). Thus, photoreceptor transplantation is possible, even into the
mature recipient retina, provided that the donor cells are at the correct
stage in development at the time of transplantation (Bartsch et al.,
2008; MacLaren et al., 2006).
2.1.3. Function
Transplanted rod-precursor cells are able to migrate into the adult
retina and differentiate to acquire the specialized morphological fea-
tures of mature photoreceptor cells (Bartsch et al., 2008; Eberle et al.,
2012; MacLaren et al., 2006). However, the fundamental question
remained as to whether these transplanted photoreceptor cells could
actually improve vision. Although there have been reports of improve-
ment in a single measure of visual function, none had conclusively
demonstrated an impact on vision. Moreover, in these earlier studies,Nrl.GF
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Fig. 1. A. Schematic adapted fromMacLaren & Pearson et al. (2006), summarising how the dev
recipient retina. Integration-competent cells can be identiﬁed by the post-mitotic rodmarker, N
within the recipient retina circuitry. B. Examples of Nrl.GFP + ve donor cells transplanted into
and Barber et al. (2013). Integrated donor cells express the protein missing in the recipient phthe percentage of cells able to integrate and make connections was ex-
tremely low (b1000 cells per transplant) (Bartsch et al., 2008;MacLaren
et al., 2006) and could restore only basic light sensitivity to the retina.
Thus a major challenge for the cell suspension approach was, and in-
deed still is, to generate sufﬁcient numbers of transplantable cells and
in parallel to achieve high integration efﬁciency. By optimizing the
transplantation protocols sufﬁciently to increase integration efﬁciency
~30 fold, Pearson, Ali and colleagueswere able to provide theﬁrst deﬁn-
itive proof of functional rod-mediated vision after photoreceptor trans-
plantation in a mouse model of congenital stationary night blindness
(Pearson et al., 2012). Three weeks after transplantation, the newly in-
tegrated donor rod cells are light sensitive, have dim-ﬂash kinetics
very similar to wild type rods and form classic triad synaptic connec-
tionswith second-order bipolar and horizontal cells in the recipient ret-
ina. Moreover, the visual signals generated by transplanted rods are
projected to higher visual areas, including V1 of the visual cortex, and
are capable of driving visually guided behaviour. Of note, therewas a ro-
bust positive correlation between the number of integrated cells and the
amount of visual function restored. Interestingly, in contrast to some re-
ports, the authors found that despite robust integration of transplanted
photoreceptors, the levels achieved were still insufﬁcient to drive an
electroretinogram (ERG) response in the recipient retinae. The ERG is
recorded at the corneal surface and is an average of the electrical re-
sponses of all the cells in the retina in response to a light stimulus. By
using gene replacement in the samemodel, Pearson et al. demonstratedP photoreceptors
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elopmental stage impacts on the ability of donor cells to migrate and integrate within the
rl. Cells taken from this stage of development are capable ofmigrating into and integrating
the Gnat1−/−murinemodel of stationary night blindness taken from Pearson et al. (2012)
otoreceptors, rod α-transducin.
488 R.A. Pearson / Biotechnology Advances 32 (2014) 485–491that approximately 120,000 functioning rod photoreceptors were
required to generate a reproducible scotopic ERG response (Pearson
et al., 2012).
2.2. Challenges in repairing the degenerating retina
2.2.1. The role of the recipient retina in transplantation outcome
Photoreceptor transplantation is proposed as a broad treatment
strategy, applicable to all photoreceptor degenerations. This requires
the efﬁcient integration of donor cells within the degenerating retinae
since, to date, the best transplants have been achieved in normal retinae
and retinae with relatively mild degeneration. Recently, the ﬁrst com-
prehensive assessment of rod-photoreceptor transplantation across dif-
ferent models of inherited photoreceptor degeneration was described
(Barber et al., 2013). Importantly for clinical application, the study
found that photoreceptor transplantation is feasible in all models
examined, including severely degenerated retinae. However, disease
type impacts signiﬁcantly on both the number and the morphology of
integrated rods. For example, rod precursors transplanted into the
Gnat1−/− model of stationary night blindness integrated in numbers
similar to healthy wild type retina and formed robust outer segments
and synaptic connections. Conversely, cells transplanted into the mod-
erately fast degenerating rhodopsin knockout, integrated poorly and
rarely elaborated outer segments or synapses. In contrast, this and an-
other recent report found that transplants into the PDE6βrd1/rd1 model,
which degenerates rapidly, demonstrate surprisingly good integration
and even some restoration of visual function, although the resulting
morphology of the transplanted photoreceptors is poor (Barber et al.,
2013; Singh et al., 2013).
Successful photoreceptor transplantation requires the donor cell to
migrate from the site of transplantation – typically the subretinal space
– through the inter-photoreceptor matrix (IPM), across the outer limit-
ingmembrane (OLM), a series of tight-junctions that separate theneural
cell bodies from the inner/outer segments of the photoreceptors, and
into the recipient outer nuclear layer (ONL) (Warre-Cornish et al.,
2013). Two factors that change to variable extents in different models
of degeneration, namely the integrity of the OLMand the extent of recip-
ient retinal gliosis, have been found to play key roles in determining the
success of transplanted donor cell migration and integration (Barber
et al., 2013; Kinouchi et al., 2003; Pearson et al., 2010;West et al., 2008).
2.2.2. Photoreceptor transplantation outcome and gliosis
Gliosis is well known to be a limiting factor in the regeneration of
other areas of the CNS such as the spinal cord. Reactive gliosis is thought
to represent a cellular attempt to protect the surrounding tissue from
further damage, to promote repair and to limit neuronal remodelling
(Eng and Ghirnikar, 1994). It includes morphological, biochemical and
physiological changes, which can vary with the type and severity of
the insult. In the retina, gliosis primarily involves the Muller glial cells,
which undergo upregulation of the intermediate ﬁlament proteins
vimentin and glial ﬁbrillary acidic protein (GFAP), hypertrophy of the
Muller glial terminal processes at the edge of the ONL (Bignami and
Dahl, 1979) and a concomitant increase in the deposition of inhibitory
extracellular matrix (ECM) molecules, including Chondroitin Sulphate
Proteoglycans (CSPGs) (Inatani et al., 2000; Landers et al., 1994). Like
elsewhere in the CNS, the glial scar in the retina may represent a phys-
ical barrier to cell migration or act as a reservoir of inhibitory ECMmol-
ecules or a combination of these. Indeed, gliosis can impact on the
efﬁcacy of many proposed therapeutic approaches including the efﬁ-
ciency of viral transduction in gene therapy (Calame et al., 2011) and
impair the ability of retinal grafts and electronic implants to contact
the underlying retina (Zhang et al., 2003). Similarly, photoreceptor
transplantation outcome is inversely correlated with the extent of
GFAP expression and deposition of CSPGs (Barber et al., 2013). Trans-
plantation studies into the retinae of GFAP−/vimentin− double knock-
out mice have also reported an increase in integration compared towild type animals (Kinouchi et al., 2003) although the precise mecha-
nism behind this is unclear. CSPGs bind many different ECM proteins
and growth factors making them important players in a variety of regu-
latory processes including cell adhesion and migration. In the CNS,
CSPGs are upregulated after injury and participate in the inhibition of
axon regeneration mainly through their GAG side chains. Our under-
standing of their role in retinal degeneration is limited. Using the
broad-spectrum CSPG antibody CS-56 we have seen very different pat-
terns of expression in different models of degeneration (Barber et al.,
2013). A recent study showed the CSPG, aggrecan, to be markedly up-
regulated in two rat models of retinal dystrophy (Chen et al., 2012),
while microarray analysis of individual Muller glial cells from a mouse
model of RP identiﬁed a signiﬁcant increase in CSPG5 (neuroglycan)
(Roesch et al., 2012). ChABC, a broad-spectrum chondroitinase that
can break down a number of CSPGs has been used with good effect in
promoting axonal regrowth in the damaged spinal cord. Similarly, ap-
plication of ChABC can break down retinal CSPGs and improve photore-
ceptor transplantation outcome in some models (Barber et al., 2013;
Singhal et al., 2008; Suzuki et al., 2007). Matrix Metalloproteases
(MMPs) are proteolytic enzymes that degrade ECM molecules, includ-
ing collagen, ﬁbronectin, laminin, and a variety of proteoglycans. In-
ducers of MMP-2 activity have been shown to promote transplanted
donor cell migration into the recipient retina and there have been suc-
cessful developments of biodegradable polymers to deliver MMPs in
conjunction with cell transplants (Suzuki et al., 2006; Yao et al., 2011;
Zhang et al., 2007).
2.2.3. Photoreceptor transplantation outcome and the OLM
The observation that the ability of transplanted cells to integrate
within the host opossum retina decline with host maturation, made
by Sakaguchi et al. (Sakaguchi et al., 2003, 2004), is striking since this
coincides with the formation of anatomical barriers within the host ret-
ina including the OLM, a series of adherens junctions between the ter-
minal processes of the Muller glia and the inner segments of the
photoreceptors. Similarly, there is an inverse correlation between the
degree of transplanted photoreceptor integration and OLM integrity. In
mice with retinal dystrophy caused by defects in Crumbs homologue-1
(Crb1), a protein associated with OLM adherens junction formation and
stabilization, the OLM is disrupted and transplanted photoreceptor pre-
cursor integration is signiﬁcantly higher than wild type controls with an
intact OLM (Barber et al., 2013; Pearson et al., 2010). However, OLM
integrity is maintained in a number of retinal degenerations caused by
other gene defects and transplant outcome is markedly worse in these
models (Barber et al., 2013). This suggests that the OLM remains a
signiﬁcant barrier to transplanted photoreceptor cell integration in
many forms of retinal degeneration. Support for this notion comes from
the ﬁnding that pre-treatment of the recipient retina with the glial toxin
α-aminoadipic acid (AAA), which disrupts the integrity of the OLM,
leads to an increase in photoreceptor precursor cell integration (West
et al., 2008). AAA would not be suitable for clinical application due to its
toxic effects on the supportive Muller glia (Pedersen and Karlsen, 1979).
An alternative strategy is to induce transient OLM disruption using
small interfering ribonucleic acid (siRNA) to promote transcriptional
gene silencing of OLM-related proteins. Proof of principle for this strategy
has been demonstrated using siRNA targeted against the adherens junc-
tion protein ZO-1, which signiﬁcantly improves transplantation outcome
both in wild type and degenerate retinae (Barber et al., 2013; Pearson
et al., 2010). ZO-1 is not an ideal target however since it is also expressed
throughout the RPE and silencing it can lead to RPE proliferation. A target
whose expression is restricted to the OLM would therefore be ideal.
2.3. Renewable sources of donor cells
The ﬁndings described above deﬁne a strategy for photoreceptor cell
replacement therapy and overcome a number of obstacles. They show
that cell replacement is feasible provided the correct stage cell is
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tential hazards associated with tumour formation due to unregulated
proliferation of transplanted undifferentiated stem cells. However, the
postmitotic photoreceptor precursor cells used in these studies are de-
rived from the early postnatal mouse retina. The equivalent stage in
human development occurs early in the second trimester. Putting the
obvious ethical considerations aside, such tissue is in very limited sup-
ply and of variable quality. An expandable source of cells that could be
cultured in vitro to the correct ontogenetic stage for transplantation
may, therefore, represent a more appropriate and reproducible source
of photoreceptor precursor cells. These ﬁndings have renewed interest
in the potential to generate new photoreceptor precursors from various
stem cell sources. A few of the more promising are brieﬂy discussed
below.While beyond the scope of the current review, there is also inter-
est in the ability of stem cells to perform neuroprotective roles (see
review by Bull and Martin, 2011).
2.3.1. Embryonic stem cells
Pluripotent embryonic stem (ES) cells have undoubtedly yielded the
most promising results to date with regard to generating retinal
cell types. ES cells are derived from the inner cell mass of the pre-
implantation blastocyst. They are able to maintain an undifferentiated
state or can be directed to mature along lineages deriving from all
three germ layers—ectoderm, endodermandmesoderm. Several studies
have produced convincing demonstrations of the generation of retinal
cells in vitro frommouse,monkey and human ES cells using growth fac-
tors, retinal co-culture and genetic modiﬁcation (Lamba et al., 2009;
Osakada et al., 2009). Following the pioneering work by Watanabe
and colleagues on telencephalic speciﬁcation (Watanabe et al., 2005),
Ikeda and colleagues used antagonists of the nodal (LeftyA) and Wnt
(DKK-1) pathways in addition to activin-A and serum to derive mouse
retinal progenitor cells (Rx+/Pax6+) after 10 days of differentiation.
These ES-derived cells were able to integrate, albeit in small numbers,
into embryonic retinal explants and expressed markers of retinal cell
types including the photoreceptor photopigment, rhodopsin (Ikeda
et al., 2005).Mouse ES cells were further directed towards retinal differ-
entiation by the inhibition of the Notch signaling pathway (Osakada
et al., 2009), which has been demonstrated to promote photoreceptor
differentiation. Using a different but related approach, Reh and col-
leagues exposed human ES cells to Noggin (a Bmp inhibitor), IGF-1
and DKK-1 (Lamba et al., 2006). Under these conditions, almost 80% of
the cells were directed to a retinal fate (Pax6+/Chx10+) within
3 weeks and ~12% of these went on to express the transcription factor
and cone/rod photoreceptor precursor marker, Crx. Meyer and col-
leagues avoided the use of recombinant protein – an important require-
ment for translation into clinical application – using a system that takes
advantage of the endogenous secretion of DKK-1 and Noggin by ES cells
in neural differentiation media. The generation of Rx+ neural rosettes
and their subsequent culture as neurospheres gave rise to retinal pro-
genitors after 40 days (26% of cells were Chx10+) and by day 80, 20%
of the neurospheres contained Crx+ photoreceptor precursors (Meyer
et al., 2009). Together these demonstrate the ability to direct ES cells
towards a retinal fate. However, it has proved harder to show that
these cells can integrate as well as those isolated from the postnatal
retina. Integration has been observed following the transplantation of
ES-derived retinal cell (Lamba et al., 2006, 2009), although others
have found that cells derived using similar protocols integrate only
poorly, if at all (Ikeda et al., 2005; West et al., 2012).
In a recent ground-breaking study, Eiraku et al. have developed a
3-D culture system that enables ES cells to self-organise and mimic
the morphological development of the retina (Eiraku et al., 2011). Un-
like many of the 2D methods described above, this system appears to
allow a more complete development of the photoreceptors. Indeed, a
recent report by Ali, Pearson and colleagues (Gonzalez-Cordero et al.,
2013) shows that this 3-D system permits the generation of large num-
bers of stage-speciﬁc photoreceptors that are capable of integration andmaturation following transplantation into both wild type and
degenerating retinas at speciﬁc stages of development. Thus far, the ef-
ﬁciency is low and optimisation will be required in order to assess
whether these cells are capable of restoring visual function, as has
been demonstrated for donor cells isolated from the developing post-
natal retina.
2.3.2. Induced pluripotential stem cells
Although mouse, monkey and human ES cells have all been used to
generate retinal cells, including photoreceptors, they are not without
limitations. The derivation and use of human ES cells are limited by
the restricted availability of human embryos, low efﬁciency of isolation
of human ES cells, the potential for immune rejection of non-matched
tissue (West et al., 2010), and by ethical concerns surrounding the de-
struction of human embryos for the purpose of cell isolation. One way
to avoid these issues is by reprogramming the nuclei of differentiated
somatic cells to a pluripotent state. The now seminal work by Takahashi
and Yamanaka (Takahashi and Yamanaka, 2006) demonstrated that
just four transcription factors (Oct4, Sox2, c-Myc and Klf4)were needed
to turn adult mouse ﬁbroblasts into a pluripotential stem cell that had
characteristics very similar to ES cells, including multipotentiality and
self-renewal. The use of iPS cells avoids many of the limitations of ES
cells noted above. Like ES cells, it offers the prospect of providing retinal
cells or even entire retina for the production of donor cells for transplan-
tation but iPS cells can additionally be derived from patients with
inherited retinal disorders to study disease mechanisms and develop
new targets for therapy (e.g. Jin et al., 2011; Singh et al., 2013). Howev-
er, since such cells would be derived from the patient themselves, they
would also require replacement of the dysfunctional gene that led to the
degeneration in the ﬁrst place (Howden et al., 2011).
Induced pluripotent stem cells are very similar to ES cells and
should, theoretically, have a similar capacity to adopt a retinal fate. Sev-
eral protocols similar to those described above for ES cells have been
tested on mouse and human iPS cells. While several have resulted in
cells expressing markers of retinal fate, including photoreceptors, the
efﬁciency of retinal differentiation appears to vary, at least between
human iPS and ES cells. Although the protocols described by Lamba,
Osakada and colleagues can generate photoreceptor-like cells at a sim-
ilar efﬁciency to ES cells (Lamba et al., 2006, 2010; Osakada et al.,
2009), Hirami, and others reported that some iPS cell lines can be resis-
tant to retinal differentiation (Hirami et al., 2009). Evenwithin the lines
that do permit retinal induction, there is signiﬁcant variation in terms of
efﬁciency. Nonetheless, as we begin to developmore effective protocols
for ES differentiation, so too is it likely that iPS differentiation will also
improve and these cells remain an exciting avenue of investigation for
sources of donor cells.
2.3.3. Retinal stem cells
In lower vertebrates, the eye continues to grow throughout the life
of the organism. Newneurons are produced from a region called the cil-
iary marginal zone (CMZ), a site of continual retinal neurogenesis and a
stem cell niche at the anterior margin of the retina (Reh and Levine,
1998). Regenerative potential in the central retina is more limited. A
population of rod precursor cells exists in teleost ﬁsh that can regener-
ate all retinal neuronal types after damage (see Raymond et al., 2006).
Similarly, recent work showed that in zebraﬁsh Muller glial cells can
function as multipotent retinal stem cells (RSCs) that respond to the
loss of photoreceptors by speciﬁcally regenerating the missing neurons
(Bernardos et al., 2007; Ramachandran et al., 2010, 2012). Exciting re-
cent developments also hint at the possibility of reactivating theMuller
glial cells of the mammalian retina in a similar matter, although gener-
ation of photoreceptors from these cells appears limited (Karl and Reh,
2010; Karl et al., 2008).
In the embryonic chick, the cells at the retinal margin, a zone highly
reminiscent of the lower vertebrate CMZ, also display signiﬁcant regen-
erative capacity. Dissociated cells derived from this region retain the
490 R.A. Pearson / Biotechnology Advances 32 (2014) 485–491capacity to proliferate and form organized laminar re-aggregates be-
yond the time of normal neurogenesis in the developing retina (Layer
and Willbold, 1989; Willbold and Layer, 1992). These stem cell-like
cells persist in the periphery of the adult chicken eye and can be induced
to proliferate and add new neurons and glia to the retinal margin
(Fischer and Reh, 2000; Fischer et al., 2002). Although the adult mam-
malian eye appears to lack such regenerative capabilities, Van der
Kooy and Ahmad independently reported that the mammalian ciliary
epithelium (CE), part of the ciliary body, a structure analogous to the
lower vertebrate CMZ, contains a population of stem-like cells (Tropepe
et al., 2000). While quiescent and of unknown function during adult
life, these cells demonstrate characteristics typical of neural stem cells,
including multipotentiality and self-renewal when cultured in vitro.
Single pigmented CE cells clonally proliferate in vitro in the presence of
the mitogens FGF and EGF to form sphere colonies of cells (termed
neurospheres). When differentiated, they reportedly expressed markers
of rod, bipolar cell and Muller glial markers, as assessed by immunocyto-
chemistry (Ahmad et al., 2000; Giordano et al., 2007; Tropepe et al.,
2000). Follow-up research with human and pig CE cells introduced tech-
niques to expand these cells in monolayer cultures (Coles et al., 2004;
MacNeil et al., 2007). However, the lack of robust criteria for deﬁning
the progeny and fate of these cells in vitro hasmade it difﬁcult to evaluate
the ability of these cells to differentiate into rods. Indeed other groups
have recently called into question the full multipotentiality of these cells
and thus their classiﬁcation as true stem cells (Cicero et al., 2009;
Gualdoni et al., 2010). Nonetheless, they remain a population of cells
with signiﬁcant proliferative capacity and appear to be evolutionarily re-
lated to the true retinal stem cells found in lower vertebrates and are thus
worthy of consideration. Given recent demonstrations of the importance
of the conditions inwhich embryonic stem (ES) cells are grown in for de-
termining cell fate (Eiraku et al., 2011) it remains possible that these cells
have the potential to generate retinal cell types under the right circum-
stances (Fang et al., 2013; Kiyama et al., 2012).
2.4. One eye on the future
While there are still a number of steps to be addressed before
photoreceptor transplantation can be effectively applied in the clinic,
the prospect is looking ever more realistic. The ﬁrst clinical trials
transplanting ES-derived retinal cells, including ES-derived RPE for the
treatment of Stargardt's disease, are under way in the USA and the UK
(Schwartz et al., 2012). These represent important landmarks in the de-
velopment of cell therapies for blinding retinal diseases. Of particular
importance will be the assessments to conﬁrm a lack of tumorogenicity
and whether such grafts are subject to immunological reaction.
Perhaps the greatest challenge yet to be addressed is cone photore-
ceptor transplantation. Themouse is nocturnal and thus has a rod dom-
inant retina that lacks a macula, the region of high-density cones that
permits high visual acuity. For clinical application, however, cones are
clearly of great importance. While the same principles appear to apply
for cones as for rods, in so far as they must be post-mitotic in order to
integrate (Lakowski et al., 2010), they do so only at very low efﬁciency.
However, building upon the knowledge gained in the transplantation of
rod photoreceptors, it is surely only a matter of time before restoring
cone-mediated vision is achieved.
3. Conclusions
The need for new therapeutic approaches that can not only halt but
also reverse the loss of sight after degeneration has occurred has created
intense interest in the potential of photoreceptor replacement by trans-
plantation. Recent advances in transplantation and stem cell technology
mean that this is now a realistic prospect. Transplanted donor photore-
ceptors have been shown to migrate and integrate within the neuronal
circuitry of the recipient retina. Moreover, these cells are capable of re-
storing vision at the behavioural level. Large numbers of potentiallytransplantable cells can now be generated from embryonic stem cells
by growing optic cup like structures in vitro. While iPS cells lag a little
way behind, these too are showing great potential both as donor
sources and as systems for disease modeling. Together, these advances
provide hope that stem cell therapies for the treatment of retinal degen-
eration may soon move towards clinical application.
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ES Embryonic Stem (cell)
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ECM Extracellular Matrix
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siRNA small interfering ribonucleic acid
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